ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 162 filers reported holding ANTARES PHARMA INC in Q4 2021. The put-call ratio across all filers is 0.75 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $52,000 | +15.6% | 12,645 | 0.0% | 0.00% | – |
| Q4 2021 | $45,000 | -37.5% | 12,645 | -36.0% | 0.00% | – |
| Q3 2021 | $72,000 | -63.1% | 19,747 | -55.8% | 0.00% | – |
| Q2 2021 | $195,000 | +163.5% | 44,642 | +147.0% | 0.00% | – |
| Q1 2021 | $74,000 | -1.3% | 18,073 | -4.0% | 0.00% | – |
| Q4 2020 | $75,000 | -53.1% | 18,827 | -68.2% | 0.00% | – |
| Q3 2020 | $160,000 | +11.1% | 59,137 | +12.9% | 0.00% | – |
| Q2 2020 | $144,000 | +242.9% | 52,367 | +193.8% | 0.00% | – |
| Q1 2020 | $42,000 | -54.8% | 17,822 | -9.7% | 0.00% | – |
| Q4 2019 | $93,000 | +89.8% | 19,747 | +34.4% | 0.00% | – |
| Q3 2019 | $49,000 | -19.7% | 14,690 | -20.7% | 0.00% | – |
| Q2 2019 | $61,000 | +45.2% | 18,530 | +33.8% | 0.00% | – |
| Q1 2019 | $42,000 | +10.5% | 13,850 | 0.0% | 0.00% | – |
| Q4 2018 | $38,000 | -17.4% | 13,850 | +1.4% | 0.00% | – |
| Q3 2018 | $46,000 | +24.3% | 13,660 | -4.3% | 0.00% | – |
| Q2 2018 | $37,000 | +19.4% | 14,270 | 0.0% | 0.00% | – |
| Q1 2018 | $31,000 | +10.7% | 14,270 | 0.0% | 0.00% | – |
| Q4 2017 | $28,000 | -79.4% | 14,270 | -66.0% | 0.00% | – |
| Q3 2017 | $136,000 | +189.4% | 41,940 | +187.5% | 0.00% | – |
| Q2 2017 | $47,000 | +193.8% | 14,590 | +7.4% | 0.00% | – |
| Q4 2015 | $16,000 | -33.3% | 13,591 | -4.9% | 0.00% | – |
| Q3 2015 | $24,000 | -17.2% | 14,291 | +3.6% | 0.00% | – |
| Q2 2015 | $29,000 | -12.1% | 13,791 | +12.2% | 0.00% | – |
| Q1 2015 | $33,000 | +3.1% | 12,291 | 0.0% | 0.00% | – |
| Q4 2014 | $32,000 | -25.6% | 12,291 | -23.9% | 0.00% | – |
| Q2 2014 | $43,000 | +13.2% | 16,144 | +49.6% | 0.00% | – |
| Q1 2014 | $38,000 | -24.0% | 10,791 | -3.6% | 0.00% | – |
| Q4 2013 | $50,000 | +6.4% | 11,191 | -4.3% | 0.00% | – |
| Q3 2013 | $47,000 | 0.0% | 11,691 | +3.5% | 0.00% | – |
| Q2 2013 | $47,000 | – | 11,291 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sargent Investment Group, LLC | 4,598,329 | $10,852,000 | 4.99% |
| Soleus Capital Management, L.P. | 864,100 | $2,039,000 | 2.37% |
| Healthcare Value Capital, LLC | 500,000 | $1,180,000 | 1.98% |
| ORACLE INVESTMENT MANAGEMENT INC | 1,227,114 | $2,896,000 | 0.86% |
| PERKINS CAPITAL MANAGEMENT INC | 232,166 | $548,000 | 0.66% |
| Stonepine Capital Management, LLC | 151,189 | $357,000 | 0.38% |
| Zebra Capital Management LLC | 84,963 | $200,000 | 0.32% |
| Intrinsic Edge Capital Management LLC | 1,000,000 | $2,360,000 | 0.31% |
| Alambic Investment Management, L.P. | 46,069 | $109,000 | 0.26% |
| OBERWEIS ASSET MANAGEMENT INC/ | 200,600 | $473,000 | 0.26% |